查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1757976

全球血管移植市场

Artificial Blood Vessels
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 274 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

预计到 2030 年全球血管移植市场规模将达到 3.795 亿美元

全球血管移植市场规模预计在2024年为2.927亿美元，到2030年将达到3.795亿美元，在2024-2030年的分析期间内，复合年增长率为4.4%。氧环己酮聚合体是本报告分析的细分市场之一，预计其复合年增长率为5.4%，到分析期结束时规模将达到1.779亿美元。弹性体聚合物细分市场在分析期间的复合年增长率预计为3.0%。

美国市场规模估计为 7,970 万美元，中国市场预计复合年增长率为 8.2%

美国血管移植市场规模预计2024年达到7,970万美元。作为世界第二大经济体，中国预计在2030年达到7,910万美元的市场规模，2024年至2030年的复合年增长率为8.2%。其他值得关注的区域市场包括日本和加拿大，预计在分析期间的复合年增长率分别为1.8%和3.5%。在欧洲，预计德国的复合年增长率为2.6%。

全球血管假体市场－主要趋势与驱动因素摘要

生物工程血管移植：心血管外科的未来？

血管移植市场正蓬勃发展，主要原因是心血管和周边动脉疾病对可靠血管移植的需求不断增长。合成和生物工程血管正在血管外科手术中发挥变革性的作用，尤其适用于自体血管无法移植的患者。传统上，血管移植主要使用发泡聚四氟乙烯 (ePTFE) 和聚酯纤维等材料，如今，人们开始转向模拟自身血管结构和功能的组织工程血管移植 (TEVG)。这些新型血管移植已展现出卓越的生物相容性、较低的血栓形成风险和更高的通畅率。 3D 生物列印和支架製造技术的进步正在突破客製化的界限，使患者特异性的血管移植成为可能，从而改善手术效果。此外，干细胞技术和再生医学的创新使得能够创建与宿主组织无缝整合并促进内皮化的移植血管成为可能。这对于需要随儿童成长进行血管重组的儿科患者尤其有益。奈米技术与表面改质的结合，进一步增强了合成移植物的机械强度和抗发炎特性。此外，对去细胞天然血管的研究，为新的现成解决方案铺平了道路，这些解决方案将天然组织的结构完整性与无菌移植物的安全性相结合。该领域处于生物技术、材料科学和临床医学的交叉点，标誌着心血管修復与重组未来迈出了重要的一步。

日益加重的疾病负担和手术需求如何影响市场趋势？

全球心血管疾病（CVD），尤其是动脉硬化、动脉瘤和周边动脉疾病的负担，是血管移植市场扩张的强大驱动力。世界人口老化，加上久坐不动的生活方式以及肥胖和糖尿病发病率的上升，导致血管併发症通常需要外科手术干预。在许多情况下，患者本身没有适合移植的静脉或动脉，这使得合成替代物不仅是一种选择，更是一种必需品。冠状动脉绕道手术手术（CABG）和末期肾衰竭患者的血液透析机通路是合成移植物最常被广泛使用的应用领域。包括微创血管外科在内的新型外科技术正在推动对灵活、耐用且适应性强的合成移植物的需求。同时，已开发国家和新兴国家的医疗保健系统都在扩大其执行复杂血管介入的能力，从而增加了手术量，进而增加了器械使用量。此外，无论是军事还是民用领域，涉及大血管的创伤、先天性心臟疾病和肿瘤切除术也推动了其使用案例的增加。在中低收入国家，外科基础设施的改善和政府对心臟照护的投入进一步推动了市场渗透。紧急手术对可靠血管导管的需求，加上全球对血管健康的日益关注，使得血管移植物成为现代外科手术方案的前沿。

监管和临床挑战是否正在改变创新格局？

儘管技术不断进步，血管移植市场仍受复杂的法规环境和临床挑战的影响。由于心血管应用的高风险性，血管移植（尤其是组织工程和生物可吸收移植）的监管核准流程极为严格。其安全性、耐用性、生物相容性和长期疗效必须透过临床前和多期临床试验进行全面验证。这通常会导致产品开发週期延长和成本增加，除非与成熟的医疗设备公司或学术机构合作，否则小型创新企业将难以进入市场。此外，移植排斥反应、感染风险、动脉瘤变性以及小直径移植（尤其是 6 毫米或更小）的通畅性有限等问题仍然是临床应用的重大障碍。这些挑战促使人们进行大量研究，旨在开发将合成支架与生物成分结合的混合移植，以降低免疫抗原性并提高完整性。生物技术公司、大学和医院之间的合作在寻求克服转化差距和简化临床检验流程的相关人员中变得越来越普遍。此外，上市后监测和基于价值的医疗保健指标的实施，正迫使製造商投资于长期疗效研究和真实世界证据。在全球范围内，市场准入受到不同报销政策的影响，尤其是在新兴国家，高昂的移植成本可能会限制其应用。然而，政府支持的创新生态系统和私人对医疗技术研发投资的不断增加，逐渐改变这些动态，推动推出更具临床和商业性可行性的下一代血管移植物。

推动全球市场成长的主要因素有哪些？

血管移植市场的成长受到多种因素的驱动，这些因素深深植根于临床需求、技术创新、不断扩大的医疗基础设施以及不断变化的治疗模式。其中最主要的是全球心血管和周边血管手术数量的增加。这主要是由于生活方式驱动的慢性疾病和与老龄化相关的血管退化的盛行率不断上升。生医材料技术的进步，例如生物分解性聚合物和生物活性涂层的开发，使得能够製造出抗感染、血栓症和抗机械疲劳的血管移植。 3D 列印（尤其是生物列印）的快速发展使得能够生产根据个体解剖结构量身定制的移植，从而减少併发症并提高手术成功率。由于接受慢性肾臟替代治疗的患者对血管通路解决方案的需求很高，透析基础设施的扩展也是一个主要的成长动力。此外，越来越多的专业心血管中心（尤其是在新兴市场），正在将人工移植纳入其标准手术套件包中。消费者行为也发挥作用，越来越多的患者选择微创手术，这些手术需要更早的手术介入和更高性能的移植材料。医院、研究机构和外科中心等终端使用者越来越倾向于与医疗设备公司合作，共同开发下一代移植技术。此外，远端医疗和远端监控工具的兴起改善了术后管理，带来了更好的疗效，并增强了人们对使用人工移植材料的信心。这些因素共同推动全球血管移植市场迈向持续技术创新、应用日益普及和扩张式成长的时期。

部分

聚合物（氧环己酮聚合体聚合物、弹性体聚合物、聚对苯二甲酸乙二醇酯聚合物、其他聚合物）、应用（主动脉疾病应用、周边动脉疾病应用、血液透析机应用）

受访企业范例（共34家）

  • Abbott Laboratories
  • ArtiCasc 3D
  • Artivion, Inc.
  • B. Braun SE
  • Becton, Dickinson and Company
  • Cook Medical Incorporated
  • Getinge AB
  • Humacyte Inc.
  • Integra LifeSciences Holdings Corp.
  • Jiangsu Bioda Life Science Co., Ltd.
  • Johnson & Johnson
  • JOTEC GmbH
  • LeMaitre Vascular Inc.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Roumai Med
  • Smith & Nephew plc
  • Techshot Inc.
  • Terumo Corporation
  • WL Gore & Associates, Inc.

人工智慧集成

我们正在利用可操作的专家内容和人工智慧工具来改变市场和竞争情报。

Global 特定产业SLM 的典型规范，而是建立了一个从全球专家收集的内容库，其中包括视讯录影、部落格、搜寻引擎研究以及大量的公司、产品/服务和市场数据。

关税影响係数

全球产业分析师根据公司总部所在国家、製造地、进出口状况（成品和原始OEM）预测其竞争态势的变化。这种复杂且多面向的市场动态预计将以多种方式影响竞争对手，包括销货成本成本 (COGS) 上升、盈利下降、供应链重组以及其他微观和宏观市场动态。

目录

第一章调查方法

第二章执行摘要

  • 市场概览
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 竞赛

简介目录
Product Code: MCP36197

Global Artificial Blood Vessels Market to Reach US$379.5 Million by 2030

The global market for Artificial Blood Vessels estimated at US$292.7 Million in the year 2024, is expected to reach US$379.5 Million by 2030, growing at a CAGR of 4.4% over the analysis period 2024-2030. Polydioxanone Polymer, one of the segments analyzed in the report, is expected to record a 5.4% CAGR and reach US$177.9 Million by the end of the analysis period. Growth in the Elastomer Polymer segment is estimated at 3.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$79.7 Million While China is Forecast to Grow at 8.2% CAGR

The Artificial Blood Vessels market in the U.S. is estimated at US$79.7 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$79.1 Million by the year 2030 trailing a CAGR of 8.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.8% and 3.5% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 2.6% CAGR.

Global Artificial Blood Vessels Market - Key Trends & Drivers Summarized

Are Bioengineered Vascular Grafts the Future of Cardiovascular Surgery?

The artificial blood vessels market is gaining remarkable momentum, primarily driven by the need for reliable vascular grafts in cardiovascular and peripheral artery diseases. Synthetic and bioengineered blood vessels are playing a transformative role in vascular surgeries, particularly in patients where natural vessels are unsuitable for grafting. Traditionally dominated by materials like expanded polytetrafluoroethylene (ePTFE) and Dacron, the market is now witnessing a shift toward tissue-engineered vascular grafts (TEVGs) that mimic the structure and function of native blood vessels. These newer grafts offer better biocompatibility, reduced thrombogenicity, and higher patency rates. Advances in 3D bioprinting and scaffold fabrication are pushing the boundaries of customization, enabling patient-specific grafts that improve surgical outcomes. Moreover, innovations in stem cell technology and regenerative medicine have made it possible to create grafts that integrate seamlessly with the host tissue and promote endothelialization. This is particularly beneficial in pediatric patients requiring vascular reconstructions that grow along with the child. The integration of nanotechnology and surface modifications is further enhancing the mechanical strength and anti-inflammatory properties of synthetic grafts. Additionally, research into decellularized natural vessels is opening new avenues for off-the-shelf solutions that combine the structural integrity of native tissues with the safety of sterilized grafts. The field is at the convergence of biotechnology, materials science, and clinical medicine, signaling a major leap toward the future of cardiovascular repair and reconstruction.

How Are Rising Disease Burdens and Surgical Needs Influencing Market Trajectories?

The global burden of cardiovascular diseases (CVDs), especially atherosclerosis, aneurysms, and peripheral arterial disease, is a powerful driver behind the expanding artificial blood vessels market. An aging global population, combined with increasingly sedentary lifestyles and rising rates of obesity and diabetes, is contributing to a surge in vascular complications that often necessitate surgical intervention. In many cases, patients lack suitable autologous veins or arteries for grafting, making artificial alternatives not just optional but essential. Coronary artery bypass grafting (CABG) and hemodialysis access in patients with end-stage renal disease are among the most common applications where artificial grafts are extensively used. Emerging surgical techniques, including minimally invasive vascular surgeries, are increasing the demand for flexible, durable, and highly compatible synthetic grafts. Simultaneously, healthcare systems across both developed and emerging nations are expanding their capabilities to perform complex vascular interventions, thereby increasing procedural volumes and, by extension, device utilization. Furthermore, traumatic injuries, congenital heart defects, and tumor resections involving major vessels in both military and civilian populations are creating additional use cases for artificial blood vessels. In low- and middle-income countries, improving surgical infrastructure and government investment in cardiac care are further stimulating market penetration. The need for reliable vascular conduits in emergency surgeries, coupled with greater global awareness of vascular health, is placing artificial blood vessels at the forefront of modern surgical planning.

Are Regulatory and Clinical Challenges Reshaping the Innovation Landscape?

Despite substantial technological advancement, the artificial blood vessels market remains shaped by a complex regulatory environment and significant clinical challenges. Regulatory approval processes for vascular grafts, particularly tissue-engineered and bioresorbable ones, are extremely rigorous due to the high-risk nature of cardiovascular applications. Safety, durability, biocompatibility, and long-term efficacy must be extensively demonstrated through preclinical and multi-phase clinical trials. This often extends product development timelines and increases costs, limiting the entry of smaller innovators unless they partner with established medical device companies or academic institutions. Furthermore, issues like graft rejection, infection risk, aneurysmal degeneration, and limited patency in small-diameter grafts-especially those under 6mm-continue to pose significant clinical hurdles. These challenges have fueled a wave of research aimed at developing hybrid grafts that combine synthetic scaffolds with biological components to reduce immunogenicity and enhance integration. Collaborations between biotech firms, universities, and hospitals are becoming more common as stakeholders seek to overcome translational gaps and streamline clinical validation processes. Additionally, the implementation of post-market surveillance and value-based healthcare metrics is forcing manufacturers to invest in long-term outcome studies and real-world evidence. On a global scale, market access is influenced by variable reimbursement policies, particularly in emerging economies where high graft costs can limit adoption. However, government-supported innovation ecosystems and rising private investment in medtech R&D are slowly shifting these dynamics, enabling the introduction of next-generation vascular grafts with better clinical and commercial viability.

What Key Forces Are Accelerating Global Market Growth?

The growth in the artificial blood vessels market is driven by several factors that are deeply rooted in clinical needs, technological innovation, healthcare infrastructure expansion, and shifting treatment paradigms. Foremost among these is the increasing number of cardiovascular and peripheral vascular surgeries being performed worldwide, due in large part to the growing prevalence of lifestyle-induced chronic diseases and age-related vascular degeneration. Technological progress in biomaterials, such as the development of biodegradable polymers and bioactive coatings, has enabled the creation of artificial vessels that better resist infection, thrombosis, and mechanical fatigue. Rapid advancements in 3D printing, particularly bioprinting, are making it feasible to manufacture personalized grafts tailored to individual anatomy, thus reducing complications and improving surgical success rates. The expansion of dialysis care infrastructure is another major growth driver, given the high demand for vascular access solutions among patients undergoing chronic renal replacement therapy. Additionally, a growing number of specialized cardiovascular centers, especially in emerging markets, are incorporating artificial grafts into their standard surgical toolkits. Consumer behavior is also playing a role, with patients increasingly opting for early surgical intervention and minimally invasive approaches that require high-performance grafts. End-users, including hospitals, research institutions, and surgical centers, are increasingly favoring partnerships with medical device firms to co-develop next-gen graft technologies. Furthermore, the rise of telehealth and remote monitoring tools is enabling better post-operative management, improving outcomes and reinforcing confidence in artificial graft use. Collectively, these factors are propelling the global artificial blood vessels market toward a period of sustained innovation, rising adoption, and expansive growth.

SCOPE OF STUDY:

The report analyzes the Artificial Blood Vessels market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Polymer (Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer, Other Polymers); Application (Aortic Disease Application, Peripheral Artery Disease Application, Hemodialysis Application)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abbott Laboratories
  • ArtiCasc 3D
  • Artivion, Inc.
  • B. Braun SE
  • Becton, Dickinson and Company
  • Cook Medical Incorporated
  • Getinge AB
  • Humacyte Inc.
  • Integra LifeSciences Holdings Corp.
  • Jiangsu Bioda Life Science Co., Ltd.
  • Johnson & Johnson
  • JOTEC GmbH
  • LeMaitre Vascular Inc.
  • Medtronic plc
  • MicroPort Scientific Corporation
  • Roumai Med
  • Smith & Nephew plc
  • Techshot Inc.
  • Terumo Corporation
  • W. L. Gore & Associates, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Tariff Impact on Global Supply Chain Patterns
    • Artificial Blood Vessels - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Demand for Vascular Grafts in Cardiovascular Surgery Throws the Spotlight on Artificial Blood Vessels
    • Development of Biocompatible and Non-Thrombogenic Materials Improves Graft Longevity
    • Use in Coronary, Peripheral, and Dialysis-Related Procedures Sustains Diverse Clinical Demand
    • Advances in Electrospinning and Tissue Engineering Enable Scaffold-Free Vessel Fabrication
    • Focus on Small-Diameter Vessels Expands Possibilities in Coronary Applications
    • Increase in Endovascular and Minimally Invasive Techniques Spurs Compatibility Requirements
    • Integration With Drug-Eluting and Anti-Infection Coatings Enhances Post-Operative Outcomes
    • Expansion of Organ Transplant and Bypass Surgeries Drives Hospital Procurement
    • Longitudinal Studies Strengthen Evidence Base and Regulatory Confidence
    • Growing Interest in Personalized and 3D-Printed Vascular Grafts Supports Tailored Therapies
    • Use in Pediatric and Congenital Applications Highlights Unmet Needs in Niche Segments
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Artificial Blood Vessels Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Artificial Blood Vessels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Artificial Blood Vessels by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 4: World 16-Year Perspective for Artificial Blood Vessels by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Polydioxanone Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Polydioxanone Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 7: World 16-Year Perspective for Polydioxanone Polymer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Elastomer Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Elastomer Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 10: World 16-Year Perspective for Elastomer Polymer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Polyethylene Terephthalate Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Polyethylene Terephthalate Polymer by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 13: World 16-Year Perspective for Polyethylene Terephthalate Polymer by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Polymers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Polymers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 16: World 16-Year Perspective for Other Polymers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Aortic Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Aortic Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 19: World 16-Year Perspective for Aortic Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Peripheral Artery Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Peripheral Artery Disease Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 22: World 16-Year Perspective for Peripheral Artery Disease Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Hemodialysis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Hemodialysis Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 25: World 16-Year Perspective for Hemodialysis Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 26: USA Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 29: USA Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 31: USA 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • CANADA
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 37: Canada 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • JAPAN
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 43: Japan 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • CHINA
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 44: China Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 46: China 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 47: China Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 49: China 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • EUROPE
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Artificial Blood Vessels by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Artificial Blood Vessels by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Artificial Blood Vessels by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 58: Europe 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • FRANCE
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 59: France Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 61: France 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 62: France Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 64: France 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • GERMANY
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 70: Germany 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • ITALY
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 76: Italy 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • UNITED KINGDOM
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 77: UK Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 80: UK Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 82: UK 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • SPAIN
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 88: Spain 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • RUSSIA
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 94: Russia 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • REST OF EUROPE
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • ASIA-PACIFIC
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Blood Vessels by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Artificial Blood Vessels by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Artificial Blood Vessels by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2025 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • AUSTRALIA
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 115: Australia 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • INDIA
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 116: India Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 118: India 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 119: India Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 121: India 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • SOUTH KOREA
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 127: South Korea 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • LATIN AMERICA
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Artificial Blood Vessels by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Artificial Blood Vessels by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Artificial Blood Vessels by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2025 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 142: Latin America 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • ARGENTINA
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 148: Argentina 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • BRAZIL
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 154: Brazil 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • MEXICO
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 160: Mexico 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • MIDDLE EAST
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Artificial Blood Vessels by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Artificial Blood Vessels by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Artificial Blood Vessels by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2025 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 175: Middle East 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • IRAN
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 181: Iran 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • ISRAEL
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 187: Israel 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 199: UAE 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030
  • AFRICA
    • Artificial Blood Vessels Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Artificial Blood Vessels by Polymer - Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Artificial Blood Vessels by Polymer - Percentage Breakdown of Value Sales for Polydioxanone Polymer, Elastomer Polymer, Polyethylene Terephthalate Polymer and Other Polymers for the Years 2014, 2025 & 2030
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Artificial Blood Vessels by Application - Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2023 and % CAGR
    • TABLE 211: Africa 16-Year Perspective for Artificial Blood Vessels by Application - Percentage Breakdown of Value Sales for Aortic Disease Application, Peripheral Artery Disease Application and Hemodialysis Application for the Years 2014, 2025 & 2030

IV. COMPETITION